. Histological grading of tumours was evaluated in terms of well (1/3), moderately (2/3) and poorly differentiated (3/3) and according to Broders' criteria (Long & Sommers, 1969; Ozols et al., 1980).
Flow cytometry has recently been employed to determine the DNA content of human neoplastic cell populations and the percentage of cells in the cell cycle phases. For some tumours flow cytometry data have proved valuable as a prognostic indicator. The DNA content of tumour cells appeared to be related to their differentiation (better differentiated tumours were more likely to be DNA diploid whereas anaplastic tumours had DNA aneuploid content) (Laerum & Farsund, 1981; Frankfurt et al., 1984a; Friedlander et al., 1984a; Johnson et al., 1985; Coon et al., 1987) and a good correlation has been found between DNA index and survival (Coulson et al., 1984; Volm et al., 1985a; Frankfurt et al., 1986; Zimmerman et al., 1987) .
There are conflicting results on the prognostic meaning of flow cytometric parameters in ovarian cancers possibly because of the small series investigated so far (Frankfurt et al., 1986; Friedlander et al., 1984b; Rodenburg et al., 1987) . In this study we assessed the ploidy level and the percentage of cells in the various cell cycle phases on tumour tissue from 101 patients with ovanran carcinoma. The relationship between flow cytometric data, the pathological and clinical features of the tumour were investigated. Materials and methods Flow cytometric analysis was performed on 155 specimens from 101 ovarian carcinoma patients. Out of 101 patients, 30 (29%) had received chemotherapy. The majority of them were treated either with cisplatinum alone, (12 cases) or with cisplatinum, adriamycin and cyclophosphamide (10 cases). The patients' main characteristics are summarised in Table I . All patients were classified by FIGO criteria for staging (Young et al., 1982) . Histological grading of tumours was evaluated in terms of well (1/3), moderately (2/3) and poorly differentiated (3/3) and according to Broders' criteria (Long & Sommers, 1969; Ozols et al., 1980 Human leukocytes from freshly collected blood were used as standard to determine the DNA index. A standard was run before and after the tumour sample to check for drifting of the laser output. Doublets were less than 1% by morphological examination of the tumour cell suspension, and leukocyte standard always contained less than 0.8% of doublets.
Cytofluorometric analysis was performed using a 30L Cytofluorograph (Ortho Instruments, USA). The fluorescence pulses were detected in a spectrum range between 580 and 750 nm. The coefficient of variation (CV) of the standard was between 1.5 and 2.5% and in ovarian cancer cells the CV of the GI peak was 3-4%. At least 50,000 cells were measured by flow cytometry at the rate of 500cells s- (Erba et al., 1985) .
Ploidy was expressed as DNA index, representing the ratio between the G, peak of ovarian cancer cells and the GO/GI peak of leukocytes (Barlogie et al., 1983) . (Baisch et al., 1975) . The Mann-Whitney test was used for statistical analysis of the percentage of the cells in the synthesis (S) phase of the cell cycle (Giannangeli et al., 1983) . Time on study or time to death was calculated from the day of first surgery to the cut-off date or to death, if this occurred. The life-tables method (Kaplan & Meier, 1958) and the log-rank statistic (Tarone & Ware, 1977) were used respectively to estimate and compare survival curves. In order to evaluate to what extent the probability of a better survival depends on ploidy and/or percentage of cells in S phase and other explanatory variables, a multivariate analysis on survival was also done applying the Cox model (Cox, 1972) . In this analysis the main effects of ploidy and/or percentage of cells in S phase and of prognostic variables, as well as the effects of the first order interactions of the latter, were investigated. A stepwise procedure was adopted to select the final most parsimonious model containing the statistically significant sub-sets of variables and interactions.
Results
The DNA index was evaluated on 155 samples from 101 patients, as in 26 patients it was possible to make more than one DNA analysis. In 34 samples, eight pimary tumours, 22 ascitic fluids and four omental metastases, the DNA index was 1.00 (DNA diploid tumours) while in the other 121 samples, 26 primary tumours, 79 ascitic fluids and 16 metastases, the DNA index was between 0.85 and 3.00 (DNA aneuploid tumours). Four were DNA tetraploid tumours and only two had a DNA index lower than the DNA diploid tumours. Figure I shows representative DNA histograms of different samples with different DNA index. As shown in Table II , five patients had more than one aneuploid cell population and were classified as DNA multiclonality ( Figure 2) ; in patient no. 24 there were two cell clones in the primary tumour and in ascitic fluid, with different DNA indices.
As described, from 26 patients DNA content was measured on several samples to check the stability of the DNA index over time and from different lesions. Except for patient no. 5, the DNA index was very stable in different samples (Table E) Univariate analysis on survival and DNA index was performed on the whole population of 90 patients with stages III and IV (Figure 3 ). At two years the proportion of (Friedlander et al., 1984b,c; Hedley et al., 1985; Volm et al., 1985b) and other types (Barlogie et al., 1980; Frankfurt et al., 1986; Cornelisse et al., 1987) .
Considering the high percentage of DNA diploid ovarian tumours one may wonder whether they are overestimated because of the predominance of normal cells present in the sample analysed by flow cytometry. In order to exclude this possibility, we made a cytological analysis of each sample. An atypical cell population was often mixed with contaminating normal cells (particularly in the ascitic fluids); and the ratio differed from one sample to another. In many DNA diploid tumours, the ratio of normal to atypical cells was in favour of the contaminating normal cells. In none of the DNA diploid tumours analysed, however, was the percentage of tumour cells less than 10%. As we are confident that in our conditions we can detect aneuploid cells even when present in a lower proportion (e.g. in experiments in which we mixed 99% DNA diploid cells and 1% of DNA aneuploid cells, the DNA aneuploid cell population was detectable), we think it is reasonable to drop the hypothesis that the DNA diploid tumours are an artificial result due to the limit of the method used.
In six samples we found more than one cancer cell population with a different DNA index (Table II and Figure  2 ). This was in agreement with the findings of other groups for this type of tumour (Frankfurt et al., 1984a; Rodenburg et al., 1987) . The number of cases with DNA multiclonality was too small for assessing whether the presence of different neoplastic cell populations with different DNA indices has any meaning in terms of biological and clinical behaviour of the tumour.
The stability of the DNA index over tine and in different klsions, monitored in 25 patients, proved to be the same in primary tumour, metastases and ascitic fluids from the same patients and also when many paracenteses were performed over time (see Table Ill ), indicating some degree of stability of the malignant genoma (Frankfurt et al., 1984a,c; Volm et al., 1985a; Iversen & Skaarland, 1987 (Iversen & Laerum, 1985) .
That DNA index may be indicative of the degree of malignancy is also suggested by the finding that it was related to the degree of differentiation of the tumour (Table  IV) . Ploidy distribution in tumour samples was related to the size of the residual tumour in the peritoneal cavity after surgery (Table V) . Our data are in agreement with those reported by Rodenburg et al. (1987) , who found that patients with DNA diploid tumours more frequently had residual tumours smaller than 1.5cm.
Since the DNA index appears stable in the same tumour over time one can speculate that smaller tumours that can be almost completely eradicated surgically leaving a residual tumour less than 2cm are intrinsically different, perhaps less malignant, from those that are larger at diagnosis. In other words, the post-surgical residual tumour (<or >2cm) does not depend only on how early the diagnosis is made but may be inherently associated with the biological properties of the tumour.
DNA diploid tumours had a significantly lower percentage of cells in the S phase than DNA aneuploid tumours, as reported by other authors (Friedlander et al., 1983 (Friedlander et al., , 1984c Frankfurt et al., 1984b Frankfurt et al., , 1986 Iversen & Skaarland, 1987) . Even though the flow cytometric measurement of cells in the S phase does not give information on the kinetic parameters of the duration of the cell cycle phase, it could give an estimate of the proliferative activity of the tumour, as reported by Costa et al. (1981) , who found a good correlation between the estimation of proliferative activity using flow cytometry and autoradiography.
On the other hand, differences in the mean S phase between DNA diploid and DNA aneuploid tumours could well be affected by the fact that normal cells contained within a tumour may contribute to the lower S phase found in the DNA diploid tumours, and the higher value of the S phase in the DNA aneuploid tumours could to some extent be explained by an overlap of S and G2M phases of the diploid normal cells (Friedlander et al., 1983) .
When compared to the degree of malignancy (Table VI) (Friedlander et al., 1984b; Rodenburg et al., 1987) Volm et al. (1985) who found that 10 patients with a S-G2M fraction smaller than 17% did not survive longer than 14 patients with a larger percentage of cells in S-G2M phase. Also Frankfurt did not find significant influence of S phase index for the survival of patients in 35 cases of DNA aneuploid tumours (Frankfurt et al., 1986) .
Direct comparison of our data with the results of similar studies is extremely difficult because of heterogeneity in the choice of the variables used to fit the regression model, and the different numerical distribution of the patients when stratified by those variables. Our analysis studied the combined impact on survival of ploidy, tumour size, FIGO staging, grading, histotype and age. Other authors (Rodenburg et al., 1987) considered the presence of ascites, peritoneal carcinosis and size of metastasis in addition but excluded age. Among these factors stage and residual tumour size after first surgery are probably the most important. In our series we were unable to find any prognostic significance for tumour size, which in a similar analysis conducted in a much larger population of >500 patients (GICOG, 1987) 
